Literature DB >> 2539138

Endogenous inhibitor of angiotensin converting enzyme in the rat heart.

F Ikemoto1, G B Song, M Tominaga, K Yamamoto.   

Abstract

We have identified a substance in the rat heart which inhibits ACE. This substance was characterized to be a sulfhydryl (SH) protein, the SH moiety being essential for the inhibitory activity. The inhibitory activity disappeared when the extract was boiled, or the ultrafiltrate(mol.wt.less than 10,000) was used, or when the extract was pretreated with the SH-blocking agent 5,5'-dithiobis-(2-nitro benzoic acid) at 0.5mM or the SH oxidizing agent diamide at 1mM. This substance was fractionated with Thiopropyl Sepharose affinity chromatography, precipitation with 40% ammonium sulfate saturation and high performance liquid chromatography. The mode of inhibition was competitive. In the presence of 20 micrograms/ml of this substance, the contraction of rat aortic strips induced by 5 x 10(-8)M ANG I was inhibited by 60%. This endogenous inhibitor of ACE may modulate the activity of ACE in the heart, in response to alterations in the oxidation-reduction balance in the tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539138     DOI: 10.1016/0006-291x(89)92221-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

Authors:  H Schunkert; V J Dzau; S S Tang; A T Hirsch; C S Apstein; B H Lorell
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Conformational changes of blood ACE in chronic uremia.

Authors:  Maxim N Petrov; Valery Y Shilo; Alexandr V Tarasov; David E Schwartz; Joe G N Garcia; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

3.  ACE phenotyping in human heart.

Authors:  Victoria E Tikhomirova; Olga A Kost; Olga V Kryukova; Elena Z Golukhova; Naida I Bulaeva; Aigerim Z Zholbaeva; Leo A Bokeria; Joe G N Garcia; Sergei M Danilov
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

4.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Gábor Á Fülöp; Viktória Csató; Andrea Daragó; Judit Boczán; Emese Bányai; István Elek Szentkirályi; Tamás Miklós Maros; Tamás Szerafin; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

5.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Andrea Daragó; Judit Boczán; Emese Bányai; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

6.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Andrea Daragó; Judit Boczán; Emese Bányai; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.